| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 8.03B | 8.18B | 7.89B | 8.97B | 8.53B |
| Gross Profit | 1.83B | 1.99B | 1.93B | 2.14B | 2.05B |
| EBITDA | 597.78M | 701.30M | 881.56M | 974.09M | 807.26M |
| Net Income | 381.08M | 392.42M | 274.71M | 296.35M | 115.07M |
Balance Sheet | |||||
| Total Assets | 7.53B | 7.38B | 7.36B | 7.94B | 8.64B |
| Cash, Cash Equivalents and Short-Term Investments | 809.98M | 921.72M | 1.13B | 1.08B | 956.19M |
| Total Debt | 974.88M | 970.22M | 1.24B | 1.77B | 2.17B |
| Total Liabilities | 2.42B | 2.46B | 2.65B | 3.29B | 4.03B |
| Stockholders Equity | 4.62B | 4.44B | 4.24B | 4.19B | 4.10B |
Cash Flow | |||||
| Free Cash Flow | 312.70M | 334.20M | 743.40M | 702.13M | 173.30M |
| Operating Cash Flow | 637.96M | 537.08M | 944.66M | 907.90M | 463.10M |
| Investing Cash Flow | -396.42M | -58.54M | -151.69M | -92.28M | -96.83M |
| Financing Cash Flow | -370.82M | -630.95M | -859.67M | -627.31M | -431.28M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$791.44M | 3.93 | 16.16% | 4.60% | 12.73% | 9.25% | |
76 Outperform | HK$11.03B | 6.34 | 12.93% | 5.22% | 10.65% | 13.67% | |
74 Outperform | HK$12.26B | 6.78 | 9.07% | 10.16% | 1.53% | -21.76% | |
66 Neutral | HK$23.50B | 3.92 | 9.61% | 7.69% | -1.93% | -1.36% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | HK$321.25M | -12.78 | -2.53% | 4.15% | 2.32% | -88.07% | |
46 Neutral | HK$225.79M | -1.27 | -20.20% | ― | -30.43% | -97.13% |